Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dermatology
Telehealth
Hims & Hers shutters Apostrophe in favor of own skincare line
Hims & Hers acquired Apostrophe for $190 million in 2021. It has since launched its own dermatology line.
Emma Beavins
Mar 11, 2025 2:00pm
Championing equity in skin of color dermatology
Jul 31, 2024 9:21am
Hims & Hers, Hartford HealthCare partner on in-person care
Jan 12, 2024 3:50pm
'Podnosis': Gaming for better healthcare
Oct 11, 2023 6:00am
VisualDx to be accessible to AMWA members for free
Feb 24, 2023 4:45pm
New Level Ex study shows efficacy of its video game training
Feb 6, 2023 7:40am
